US Patent

US8309127 — Stable compositions of famotidine and ibuprofen

Formulation · Assigned to Horizon Pharma USA Inc · Expires 2026-07-18 · 0y remaining

Vulnerability score 65/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form.

USPTO Abstract

Stable pharmaceutical compositions of famotidine and ibuprofen in a single unit dosage form are disclosed herein. The compositions comprise a famotidine core having a reduced or minimal surface area surrounded by a layer of ibuprofen. In some embodiments, the ibuprofen is in direct physical contact with the famotidine.

Drugs covered by this patent

Patent Metadata

Patent number
US8309127
Jurisdiction
US
Classification
Formulation
Expires
2026-07-18
Drug substance claim
No
Drug product claim
Yes
Assignee
Horizon Pharma USA Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.